Charles Darwin University

CDU eSpace
Institutional Repository

 
CDU Staff and Student only
 

Prevention of opportunistic infections in immunosuppressed patients in the tropical Top End of the Northern Territory

Davis, Joshua S., Currie, Bart J., Fisher, Dale A., Huffam, Sarah E., Anstey, Nicholas M., Price, Richard N., Krause, Vicki L., Zweck, Nathan, Lawton, Paul D., Snelling, Paul L. and Selva-Nayagam, Sid (2003). Prevention of opportunistic infections in immunosuppressed patients in the tropical Top End of the Northern Territory. Communicable Diseases Intelligence,27(4):526-532.

Document type: Journal Article
Citation counts: Google Scholar Search Google Scholar
Attached Files (Some files may be inaccessible until you login with your CDU eSpace credentials)
Name Description MIMEType Size Downloads
Download this reading Davis_1712.pdf Published version application/pdf 120.29KB 62
Reading the attached file works best in Firefox, Chrome and IE 9 or later.

Title Prevention of opportunistic infections in immunosuppressed patients in the tropical Top End of the Northern Territory
Author Davis, Joshua S.
Currie, Bart J.
Fisher, Dale A.
Huffam, Sarah E.
Anstey, Nicholas M.
Price, Richard N.
Krause, Vicki L.
Zweck, Nathan
Lawton, Paul D.
Snelling, Paul L.
Selva-Nayagam, Sid
Journal Name Communicable Diseases Intelligence
Publication Date 2003
Volume Number 27
Issue Number 4
ISSN 0725-3141   (check CDU catalogue  open catalogue search in new window)
Start Page 526
End Page 532
Total Pages 7
Place of Publication Canberra, ACT, Australia
Publisher Australian Government. Department of Health and Ageing. Office of Health Protection, Surveillance Branch
HERDC Category C3 - Journal Article - Non-refereed articles (including articles in professional journals) (internal)
Abstract The population of the Top End of the Northern Territory has a high incidence of several infections of particular significance in the immunosuppressed. The following protocol for evaluation and treatment of patients prior to immunosuppression was developed in order to reduce the incidence of serious opportunistic infections. The infections discussed are Strongyloides stercoralis, tuberculosis, scabies, chronic hepatitis B, melioidosis and other bacterial infections. We recommend that all patients planned to receive more than 0.5 mg/kg/day of prednisolone for >14 days, or any more potent immunosuppressive drug, be evaluated and treated according to this protocol. Details of the rationale, evidence base, and proposed investigations and therapy for such patients are discussed.
Keywords Immunosuppression
Strongyloides stercoralis
Tuberculosis
Scabies
Chronic hepatitis B
Melioidosis
Additional Notes Current title: Communicable Diseases Intelligence Quarterly Report (ISSN: 1447-4514 (print) 1445-4866 (online))
Description for Link Link to published version
Link to publisher hompage
URL http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-2003-cdi2704-pdf-cnt.htm/$FILE/cdi2704s.pdf
https://www.health.gov.au/internet/main/publishing.nsf/Content/Home


© copyright

Every reasonable effort has been made to ensure that permission has been obtained for items included in CDU eSpace. If you believe that your rights have been infringed by this repository, please contact digitisation@cdu.edu.au.

 
Versions
Version Filter Type
Access Statistics: 98 Abstract Views, 63 File Downloads  -  Detailed Statistics
Created: Fri, 12 Sep 2008, 08:35:25 CST by Administrator